COVID-19, vaccine and Fall Shots
Digest more
Top News
Overview
Impacts
Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate vaccines and public health systems brace for another season of jabs and logistics.
Robert F. Kennedy Jr. secures a prominent health role, pledging reform in vaccine approval. The FDA plans significant changes under Dr. Vinay Prasad's leadership, sparking debates on the future of vaccinations.
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study. The news came a week after Election Day in 2020 and shortly after former President Joe Biden was projected to win on Nov. 7.
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.